Targeting the tissue factor coagulation initiation complex prevents antiphospholipid antibody development.
Ontology highlight
ABSTRACT: Antiphospholipid antibodies (aPL) in primary or secondary antiphospholipid syndrome (APS) are a major cause for acquired thrombophilia. Here we show that specific inhibition of the TF coagulation initiation complex with nematode anticoagulant protein c2 (NAPc2) prevents the the development of persistent aPL and circulating phospholipid-reactive B1 cells in latent viral infection and lupus prone MRL-lpr mice. NGS mRNA profiling of splenic DC in lupus mice treated with NAPc2 versus saline control uncovered a suppression of dendritic cell activation in the spleen.
ORGANISM(S): Mus musculus
PROVIDER: GSE252397 | GEO | 2024/03/21
REPOSITORIES: GEO
ACCESS DATA